rATG Versus rATG Combined With Intravenous Immunoglobulin (IVIG) Induction Immunosuppression in HLA Incompatible Transplantation (INHIBIT)
Clinical trial NCT04302805 · COMPLETED
Trial details
- NCT number
- NCT04302805
- Sponsor
- Institute for Clinical and Experimental Medicine
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-27
- Primary completion
- 2024-04-15
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.